The Natural Choice for Bespoke Healthcare Compliance

The Natural Choice for Bespoke Health and Social Care Compliance

THE CQC'S NEW FRAMEWORK | Interpreting employee wellbeing and management statements

Medication Defect Alert

Published On:

20 July 2020

Published In:

Class 4 Medicines Defect Information: Aspar Pharmaceuticals Limited, Ibuprofen 200mg and 400mg tablets packaged in various liveries, EL (20)A/30

Aspar Pharmaceuticals Limited has informed us that the Patient Information Leaflets (PILs) within the ibuprofen packs below are missing some information identified from post-marketing experience that should be documented in Section 3 (How To Take The Tablets) and Section 4 (Possible Side Effects) of the PIL.

For full details and further instructions please click here.

Request a Callback with Our Specialist Team!

Leave your contact details along with a few lines about the nature of your enquiry and a specialist member of our team will get in touch.

This website uses cookies to ensure you get the best experience on our website. Learn more

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors